{"transactions":[{"id":718223,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-03T00:15:04.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":7.01,"value":210300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.62 to $7.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":136219,"source":{"system":"sec-edgar","filing":"0001193125-26-295148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000119312526295148/ownership.xml","form_type":"4"}},{"id":779360,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-15T00:00:03.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":6.61,"value":198300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.41 to $7.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range"}],"balance_after":166219,"source":{"system":"sec-edgar","filing":"0001193125-26-224669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000119312526224669/ownership.xml","form_type":"4"}},{"id":930111,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-27T21:14:02.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":3195,"price":4.15,"value":13259.25,"ownership":{"direct":true},"balance_after":196219,"source":{"system":"sec-edgar","filing":"0001193125-26-024489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000119312526024489/ownership.xml","form_type":"4"}},{"id":940124,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-13T21:45:31.000Z","date":"2026-01-10","kind":"grant","planned":false,"acquired":true,"shares":487800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 487,800 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2027, with the remaining three quarters vesting in equal monthly installments through January 10, 2030, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":487800,"derivative":{"exercise_price":4.75,"expiration_date":"2036-01-10","underlying":"Common Stock","underlying_shares":487800},"source":{"system":"sec-edgar","filing":"0001193125-26-011837","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000119312526011837/ownership.xml","form_type":"4"}},{"id":940123,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-13T21:45:31.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":6851,"price":4.75,"value":32542.25,"ownership":{"direct":true},"balance_after":199414,"source":{"system":"sec-edgar","filing":"0001193125-26-011837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000119312526011837/ownership.xml","form_type":"4"}},{"id":1293137,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-28T23:04:53.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":206200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 206,200 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":206200,"derivative":{"exercise_price":1.18,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":206200},"source":{"system":"sec-edgar","filing":"0000950170-25-010004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017025010004/ownership.xml","form_type":"4"}},{"id":1293136,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-28T23:04:53.000Z","date":"2025-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":3211,"price":1.16,"value":3724.76,"ownership":{"direct":true},"balance_after":206265,"source":{"system":"sec-edgar","filing":"0000950170-25-010004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017025010004/ownership.xml","form_type":"4"}},{"id":1304371,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-13T22:43:56.000Z","date":"2025-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":6884,"price":1.19,"value":8191.96,"ownership":{"direct":true},"balance_after":209476,"source":{"system":"sec-edgar","filing":"0000950170-25-004939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017025004939/ownership.xml","form_type":"4"}},{"id":1665333,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T21:05:40.000Z","date":"2024-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2920,"price":9.99,"value":29170.8,"ownership":{"direct":true},"balance_after":216360,"source":{"system":"sec-edgar","filing":"0000950170-24-009382","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017024009382/ownership.xml","form_type":"4"}},{"id":1679170,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-16T21:31:02.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":92950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 92,950 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":92950,"derivative":{"exercise_price":10.09,"expiration_date":"2034-01-10","underlying":"Common Stock","underlying_shares":92950},"source":{"system":"sec-edgar","filing":"0000950170-24-004648","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017024004648/ownership.xml","form_type":"4"}},{"id":1679169,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-16T21:31:02.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2987,"price":10.09,"value":30138.83,"ownership":{"direct":true},"balance_after":219280,"source":{"system":"sec-edgar","filing":"0000950170-24-004648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017024004648/ownership.xml","form_type":"4"}},{"id":1679168,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-16T21:31:02.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":46475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 46,475 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":222267,"source":{"system":"sec-edgar","filing":"0000950170-24-004648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000095017024004648/ownership.xml","form_type":"4"}},{"id":2043826,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-27T23:07:26.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":69750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":69750,"derivative":{"exercise_price":3.57,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":69750},"source":{"system":"sec-edgar","filing":"0000899243-23-002884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924323002884/doc4.xml","form_type":"4"}},{"id":2043825,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-27T23:07:26.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":37875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":175792,"source":{"system":"sec-edgar","filing":"0000899243-23-002884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924323002884/doc4.xml","form_type":"4"}},{"id":2055726,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-12T21:12:18.000Z","date":"2023-01-10","kind":"tax_withholding","acquired":false,"shares":2987,"price":3.03,"value":9050.61,"ownership":{"direct":true},"balance_after":137917,"source":{"system":"sec-edgar","filing":"0000899243-23-001683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924323001683/doc4.xml","form_type":"4"}},{"id":2225590,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-21T20:43:37.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000899243-22-023392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924322023392/doc4.xml","form_type":"4"}},{"id":2225589,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T20:43:37.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":2.83,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-22-023392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924322023392/doc4.xml","form_type":"4"}},{"id":2436937,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-12T23:45:13.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":69475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":69475,"derivative":{"exercise_price":7.43,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":69475},"source":{"system":"sec-edgar","filing":"0000899243-22-001797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924322001797/doc4.xml","form_type":"4"}},{"id":2436936,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-12T23:45:13.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":34738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":140904,"source":{"system":"sec-edgar","filing":"0000899243-22-001797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924322001797/doc4.xml","form_type":"4"}},{"id":2598212,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-18T20:15:36.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in equal quarterly installments over 3 years."}],"balance_after":20000,"derivative":{"exercise_price":19.65,"expiration_date":"2031-08-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-033449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924321033449/doc4.xml","form_type":"4"}},{"id":2607090,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-11T20:59:22.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":4259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represented a right to purchase a total of 5,863 shares of the Issuer's common stock and has vested in full."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":4259},"source":{"system":"sec-edgar","filing":"0000899243-21-032549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924321032549/doc4.xml","form_type":"4"}},{"id":2607089,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-11T20:59:22.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":4259,"price":0.01,"value":42.59,"ownership":{"direct":true},"balance_after":106166,"source":{"system":"sec-edgar","filing":"0000899243-21-032549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924321032549/doc4.xml","form_type":"4"}},{"id":2904660,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T00:50:06.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":1604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 5,863 shares of the Issuer's common stock and will vest in equal monthly installments through July 24, 2021, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":4259,"derivative":{"exercise_price":0.01,"expiration_date":"2027-12-21","underlying":"Common Stock","underlying_shares":1604},"source":{"system":"sec-edgar","filing":"0000899243-21-002399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924321002399/doc4.xml","form_type":"4"}},{"id":2904659,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-20T00:50:06.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":1604,"price":0.01,"value":16.04,"ownership":{"direct":true},"balance_after":101907,"source":{"system":"sec-edgar","filing":"0000899243-21-002399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924321002399/doc4.xml","form_type":"4"}},{"id":2931592,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":32930,"kind":"person","name":"Pandite Arundathy N.","position":1,"cik":"0001827232","reported_name":"Pandite Arundathy N.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-28T21:50:10.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":27563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,563 shares of the Issuer's common stock, one quarter of which will vest on December 22, 2021, with the remaining three quarters vesting in equal monthly installments through December 22, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":27563,"derivative":{"exercise_price":53.02,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":27563},"source":{"system":"sec-edgar","filing":"0000899243-20-035210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827232/000089924320035210/doc4.xml","form_type":"4"}}]}